Stonebridge Capital Advisors’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-3,100
Closed -$25.5K 276
2023
Q3
$25.5K Hold
3,100
﹤0.01% 458
2023
Q2
$24.8K Sell
3,100
-500
-14% -$3.69K ﹤0.01% 478
2023
Q1
$29.2K Hold
3,600
﹤0.01% 453
2022
Q4
$22.6K Sell
3,600
-900
-20% -$6.29K ﹤0.01% 480
2022
Q3
$31K Sell
4,500
-700
-13% -$4.86K ﹤0.01% 403
2022
Q2
$43K Sell
5,200
-800
-13% -$11.2K 0.01% 366
2022
Q1
$137K Hold
6,000
0.01% 251
2021
Q4
$166K Hold
6,000
0.02% 218
2021
Q3
$167K Sell
6,000
-6,000
-50% -$170K 0.02% 209
2021
Q2
$366K Buy
12,000
+6,000
+100% +$182K 0.02% 200
2021
Q1
$190K Buy
+6,000
New +$176K 0.03% 194
2020
Q3
Sell
-8,475
Closed -$155K 234
2020
Q2
$155K Buy
8,475
+450
+6% +$7.93K 0.03% 190
2020
Q1
$124K Buy
8,025
+1,800
+29% +$43.4K 0.03% 188
2019
Q4
$186K Sell
6,225
-575
-8% -$14.9K 0.03% 189
2019
Q3
$149K Hold
6,800
0.03% 198
2019
Q2
$171K Buy
+6,800
New +$161K 0.03% 186

Other funds holding BHC

Stonebridge Capital Advisors's BHC Position: Q4 2023 in Review

Stonebridge Capital Advisors sold out of Bausch Health (BHC) in Q4 2023, closing a stake of 3,100 shares — an estimated $25.5K sold.

Stonebridge Capital Advisors first reported a position in BHC in Q2 2019 and held it in 16 quarters. The position peaked at $366K in Q2 2021. 234 funds tracked by Wall St. Rank hold BHC as of Q4 2023.

  • Stonebridge Capital Advisors reported no remaining Bausch Health position as of Q4 2023 after selling out during the quarter.
  • Stonebridge Capital Advisors sold 3,100 Bausch Health shares in Q4 2023, an estimated $25.5K.
  • Stonebridge Capital Advisors first reported a position in Bausch Health in Q2 2019 and held it in 16 quarters.
  • Stonebridge Capital Advisors's Bausch Health position peaked at $366K in Q2 2021.
  • 234 funds tracked by Wall St. Rank held Bausch Health as of Q4 2023.

Based on Stonebridge Capital Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.